Eir Medical ApS: Financial statements 2023
CVR: 43033123
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Eir Medical ApS (CVR 43033123) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 803,384 and a net result of DKK 645,414 compared with DKK 345,622 the year before. That is an increase of 71% compared with the year before. Equity in the 2023 report amounted to DKK 1,031,036. The solvency ratio was 60.1%.
- Gross Profit
- DKK 803,384
- Profit/Loss
- DKK 645,414
- Equity
- DKK 1,031,036
- Total Assets
- DKK 1,714,432
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 803 t. | 645 t. | 1 mio. | 0 |
| 2022 | - | 470 t. | 346 t. | 386 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Eir Medical ApS has published its annual report for 2022. Gross profit came to DKK 469,941, and the net result was DKK 345,622.
About Eir Medical ApS
Eir Medical ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Poul Kjædegaard Tølbøll. The company is owned by Worbech Holding ApS and Yggdrasil Tølbøll Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,157,811 and a net result of DKK 1,668,061 compared with DKK 509,341 the year before. Equity in the 2025 report amounted to DKK 3,208,438.